User menu

Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma.

Bibliographic reference Moreau, Philippe ; Avet-Loiseau, Herve ; Facon, Thierry ; Attal, Michel ; Tiab, Mourad ; et. al. Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma.. In: Blood, Vol. 118, no. 22, p. 5752-5758; quiz 5982 (2011)
Permanent URL http://hdl.handle.net/2078.1/123492